Wagner M. Zago, Chief Scientific Officer at PROTHENA CORP PUBLIC LTD CO (PRTA), sold 230,500 shares at $47.81 ($10.6M) on 2021-06-22, disclosed to the SEC on 2021-06-24.
Open-market sale of $10.6M PRTA by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.42 | 65,840 | $3.0M | 28.1% |
| 2 | $45.42 | 65,840 | $3.0M | 28.1% |
| 3 | $46.27 | 26,106 | $1.2M | 11.4% |
| 4 | $46.27 | 26,106 | $1.2M | 11.4% |
| 5 | $47.81 | 18,101 | $865K | 8.1% |
| 6 | $47.81 | 18,101 |
| $865K |
| 8.1% |
| 7 | $49.01 | 5,203 | $255K | 2.4% |
| 8 | $49.01 | 5,203 | $255K | 2.4% |
| Total | $46.15 avg | 230,500 | $10.6M | 100% |
| Filing → |
| PRTA | SELL | 2023-06-07 | $2.7M | — | Filing → |
| PRTA | SELL | 2021-02-19 | $192K | — | Filing → |
| PRTA | SELL | 2021-02-17 | $633K | — | Filing → |